An analytical method for the biomonitoring of arsenic, benzene and polycyclic aromatic hydrocarbons (PAHs) in human urine was developed using liquid chromatography tandem mass spectrometry (LC-MS/MS). The urinary metabolites of monomethylarsonic acid (MMAA), dimethylarsonic acid (DMAA), s-phenylmercapturic acid (S-PMA), and 1-hydroxypyrene (1-OHP) were selected as the corresponding marker compounds. After enzymatic deconjugation, 4 mL urine sample was extracted by 2 steps of solvent extractions. The 1-OHP was first extracted with n-hexane with 10% ethyl acetate, and MMAA, DMMA, and S-PMA were then extracted in a 2nd extraction/back-extraction using chloroform/ammonium bicarbonate aqueous solution. The two extracts were mixed and analyzed by LC-MS/MS. The method was validated with spiked urine samples. The obtained linear ranges (r2 > 0.99) of the urinary markers were 2-64 ng/mL MMAA, 1-64 ng/mL DMAA, 0.78-100 ng/mL S-PMA and 0.05-6.4 ng/mL 1-OHP. The measured accuracy (% Error) and precision (CV%) were -16.67 to 29.17% and 2.03-30.99% (3 spiked levels, 6 replicates), respectively. The method was applied to 10 real urine samples, and the presence of MMAA, DMAA, S-PMA and 1-OHP were clearly detected. The detected concentrations were BQL-8.38 ng/mL of MMAA, BQL-10.71 ng/mL of DMAA, BQL-2.55 ng/mL of SPMA, and BQL-0.17 ng/mL of 1-OHP, which were all consistent with the reported background levels.
Keywords: Arsenic; Benzene; Biomonitoring; LC–MS/MS; Polycyclic aromatic hydrocarbons.
Copyright © 2019 Elsevier B.V. All rights reserved.